(HLE) Hella KGaA Hueck - Overview
Stock: Headlamps, Rear Lamps, Sensors, Diagnostics, Accessories
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.10% |
| Yield on Cost 5y | 1.83% |
| Yield CAGR 5y | -0.26% |
| Payout Consistency | 68.5% |
| Payout Ratio | 75.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.8% |
| Relative Tail Risk | -7.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.44 |
| Alpha | -12.83 |
| Character TTM | |
|---|---|
| Beta | 0.075 |
| Beta Downside | -0.047 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.48% |
| CAGR/Max DD | 0.10 |
Description: HLE Hella KGaA Hueck January 06, 2026
HELLA GmbH & Co. KGaA (XETRA:HLE) designs, manufactures and sells automotive lighting systems and electronic components worldwide, organized into three operating segments: Lighting (headlamps, interior and exterior lighting, illuminated logos, and “phygital” front shields), Electronics (automated-driving sensors, actuators, energy-management modules, and body-electronics such as access systems), and Lifecycle Solutions (vehicle diagnostics, emissions and battery testing, calibration services, data-based services, plus wear parts and accessories for dealers and independent workshops). The Lifecycle segment also serves non-passenger-vehicle markets-including construction, agricultural, bus, truck, motor-home and marine applications.
In FY 2023 HELLA generated approximately €6.4 billion of revenue, with an adjusted EBITDA margin of roughly 7 % and R&D spending near 5 % of sales-both in line with the capital-intensive nature of the automotive-electronics sector. The company’s growth is closely tied to two macro-drivers: the rapid rollout of electric vehicles, which raises demand for high-efficiency LED and laser lighting, and the acceleration of advanced driver-assistance systems (ADAS), which fuels sales of sensors and electronic control units. A key risk is the ongoing semiconductor shortage, which could constrain production capacity and pressure margins if supply chain bottlenecks persist.
For a deeper quantitative dive into HELLA’s valuation metrics and scenario analysis, the ValueRay platform offers a transparent data set worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 161.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.79 > 1.0 |
| NWC/Revenue: 15.46% < 20% (prev 17.12%; Δ -1.66% < -1%) |
| CFO/TA 0.12 > 3% & CFO 884.0m > Net Income 161.5m |
| Net Debt (62.2m) to EBITDA (895.6m): 0.07 < 3 |
| Current Ratio: 1.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (111.4m) vs 12m ago 0.38% < -2% |
| Gross Margin: 20.50% > 18% (prev 0.24%; Δ 2026 % > 0.5%) |
| Asset Turnover: 109.5% > 50% (prev 108.9%; Δ 0.58% > 0%) |
| Interest Coverage Ratio: 1.99 > 6 (EBITDA TTM 895.6m / Interest Expense TTM 144.7m) |
Altman Z'' 3.45
| A: 0.17 (Total Current Assets 3.86b - Total Current Liabilities 2.63b) / Total Assets 7.24b |
| B: 0.39 (Retained Earnings 2.85b / Total Assets 7.24b) |
| C: 0.04 (EBIT TTM 288.3m / Avg Total Assets 7.27b) |
| D: 0.75 (Book Value of Equity 3.07b / Total Liabilities 4.12b) |
| Altman-Z'' Score: 3.45 = A |
Beneish M -3.02
| DSRI: 0.82 (Receivables 1.17b/1.43b, Revenue 7.96b/7.96b) |
| GMI: 1.16 (GM 20.50% / 23.82%) |
| AQI: 1.18 (AQ_t 0.18 / AQ_t-1 0.15) |
| SGI: 1.00 (Revenue 7.96b / 7.96b) |
| TATA: -0.10 (NI 161.5m - CFO 884.0m) / TA 7.24b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of HLE shares?
Over the past week, the price has changed by +3.31%, over one month by +0.24%, over three months by +4.98% and over the past year by -5.30%.
Is HLE a buy, sell or hold?
What are the forecasts/targets for the HLE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 65 | -22.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 85.9 | 1.8% |
HLE Fundamental Data Overview February 03, 2026
P/E Trailing = 55.8219
P/E Forward = 22.2717
P/S = 1.137
P/B = 2.9455
P/EG = 0.82
Revenue TTM = 7.96b EUR
EBIT TTM = 288.3m EUR
EBITDA TTM = 895.6m EUR
Long Term Debt = 1.00b EUR (from longTermDebt, last quarter)
Short Term Debt = 138.7m EUR (from shortTermDebt, last quarter)
Debt = 1.14b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 62.2m EUR (from netDebt column, last quarter)
Enterprise Value = 9.12b EUR (9.06b + Debt 1.14b - CCE 1.08b)
Interest Coverage Ratio = 1.99 (Ebit TTM 288.3m / Interest Expense TTM 144.7m)
EV/FCF = 36.27x (Enterprise Value 9.12b / FCF TTM 251.4m)
FCF Yield = 2.76% (FCF TTM 251.4m / Enterprise Value 9.12b)
FCF Margin = 3.16% (FCF TTM 251.4m / Revenue TTM 7.96b)
Net Margin = 2.03% (Net Income TTM 161.5m / Revenue TTM 7.96b)
Gross Margin = 20.50% ((Revenue TTM 7.96b - Cost of Revenue TTM 6.33b) / Revenue TTM)
Gross Margin QoQ = 21.17% (prev 21.71%)
Tobins Q-Ratio = 1.26 (Enterprise Value 9.12b / Total Assets 7.24b)
Interest Expense / Debt = 1.72% (Interest Expense 19.6m / Debt 1.14b)
Taxrate = 37.20% (22.4m / 60.2m)
NOPAT = 181.1m (EBIT 288.3m * (1 - 37.20%))
Current Ratio = 1.47 (Total Current Assets 3.86b / Total Current Liabilities 2.63b)
Debt / Equity = 0.37 (Debt 1.14b / totalStockholderEquity, last quarter 3.07b)
Debt / EBITDA = 0.07 (Net Debt 62.2m / EBITDA 895.6m)
Debt / FCF = 0.25 (Net Debt 62.2m / FCF TTM 251.4m)
Total Stockholder Equity = 3.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.22% (Net Income 161.5m / Total Assets 7.24b)
RoE = 5.17% (Net Income TTM 161.5m / Total Stockholder Equity 3.12b)
RoCE = 6.99% (EBIT 288.3m / Capital Employed (Equity 3.12b + L.T.Debt 1.00b))
RoIC = 5.14% (NOPAT 181.1m / Invested Capital 3.52b)
WACC = 5.62% (E(9.06b)/V(10.20b) * Re(6.19%) + D(1.14b)/V(10.20b) * Rd(1.72%) * (1-Tc(0.37)))
Discount Rate = 6.19% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.14%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈275.5m ; Y1≈180.8m ; Y5≈82.5m
Fair Price DCF = 23.10 (EV 2.63b - Net Debt 62.2m = Equity 2.57b / Shares 111.1m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -15.10 | EPS CAGR: -45.78% | SUE: 0.0 | # QB: 0
Revenue Correlation: 67.90 | Revenue CAGR: 5.27% | SUE: -0.09 | # QB: 0
EPS next Year (2026-12-31): EPS=2.04 | Chg30d=-1.083 | Revisions Net=-1 | Growth EPS=-2.9% | Growth Revenue=-4.5%